Bethesda, MD, United States of America

Gary A Clawson

This inventor holds 6 USPTO granted patents and 4 published patent applications. Top assignees: The Penn State Research Foundation, Clawnor, Inc., Musc Foundation for Research Development. Active years: 1998-2010.

USPTO Granted Patents = 6 

% Patents Active = 50.0

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 300(Granted Patents)


Location History:

  • Hershey, PA (US) (1998)
  • Bethesda, MD (US) (2001 - 2010)

Company Filing History:


Years Active: 1998-2010

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Gary A Clawson

Introduction

Gary A Clawson is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of ribozymes for therapeutic applications. With a total of 6 patents, his work has the potential to impact the treatment of various diseases.

Latest Patents

One of Clawson's latest patents focuses on tissue-specific and target RNA-specific ribozymes. This invention relates to multi-ribozymes and their use to target RNA in a tissue-specific, target RNA-specific, or pathogen-specific manner for the treatment of cancers, proliferative diseases, and infections caused by bacteria, parasites, and viruses. The invention also discusses the use of virions and viral vectors to package and deliver DNA encoding the multi-ribozymes to a host. Additionally, it covers the use of liposomes and lipid-DNA complexes for delivering DNA encoding ribozymes. Most specifically, the invention involves the use of target-specific virions to package and deliver DNA that comprises a target-specific promoter and encodes ribozymes directed at the target organism's nucleic acids. Furthermore, the invention introduces novel vectors encoding a multi-ribozyme structure with enhanced autocatalytically cleaving ribozymes.

Another significant patent by Clawson provides methods and materials for treating human papillomavirus (HPV) infections. This invention addresses HPV infections of cutaneous and mucosal epithelial cells and HPV-associated conditions such as cervical dysplasia and various cancers.

Career Highlights

Throughout his career, Gary A Clawson has worked with esteemed organizations, including the Penn State Research Foundation. His innovative work has garnered attention in the scientific community, leading to advancements in therapeutic techniques.

Collaborations

Clawson has collaborated with notable colleagues such as Wei-Hua Pan and Brian Hoel. These partnerships have contributed to the development of his groundbreaking inventions.

Conclusion

Gary A Clawson's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative treatments in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…